Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Major

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Seminars in Oncology|May 11, 2001
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development programP P Major, R E Coleman
The Journal of Biological Chemistry|October 10, 1981
5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicityD W Kufe, P P Major
Medical and Pediatric Oncology|January 1, 1982
Studies on the mechanism of action of cytosine arabinosideD W Kufe, P P Major
Canadian Medical Association Journal|August 9, 1980
Pulmonary fibrosis following therapy with melphalan: report of two casesP P Major, S Laurin, P Bettez
Cancer Detection and Prevention|January 1, 1988
Tumor-associated antigens as immunotherapy targetsN C Phillips, P P Major, H Sikorska
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1990
Enhanced expression and secretion of an epithelial membrane antigen (MA5) in a human mucinous breast tumor line (BT549)C J Williams, P P Major, A S Dion
Cancer Chemotherapy and Pharmacology|January 1, 1983
Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycinP P Major, R P Agarwal, D W Kufe
Canadian Medical Association Journal|April 8, 1978
Isolation of herpes simplex virus type 1 from lesions of erythema multiformeP P Major, R Morisset, C Kurstak, et al.
Blood|July 1, 1981
Clinical pharmacology of deoxycoformycinP P Major, R P Agarwal, D W Kufe
Cancer Research|December 1, 1982
Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNAD J Herrick, P P Major, D W Kufe
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Seminars in Oncology|May 11, 2001
Zoledronic acid in the treatment of hypercalcemia of malignancy: results of the international clinical development programP P Major, R E Coleman
The Journal of Biological Chemistry|October 10, 1981
5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicityD W Kufe, P P Major
Medical and Pediatric Oncology|January 1, 1982
Studies on the mechanism of action of cytosine arabinosideD W Kufe, P P Major
Canadian Medical Association Journal|August 9, 1980
Pulmonary fibrosis following therapy with melphalan: report of two casesP P Major, S Laurin, P Bettez
Cancer Detection and Prevention|January 1, 1988
Tumor-associated antigens as immunotherapy targetsN C Phillips, P P Major, H Sikorska
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1990
Enhanced expression and secretion of an epithelial membrane antigen (MA5) in a human mucinous breast tumor line (BT549)C J Williams, P P Major, A S Dion
Cancer Chemotherapy and Pharmacology|January 1, 1983
Clinical pharmacology of arabinofuranosyladenine in combination with deoxycoformycinP P Major, R P Agarwal, D W Kufe
Canadian Medical Association Journal|April 8, 1978
Isolation of herpes simplex virus type 1 from lesions of erythema multiformeP P Major, R Morisset, C Kurstak, et al.
Blood|July 1, 1981
Clinical pharmacology of deoxycoformycinP P Major, R P Agarwal, D W Kufe
Cancer Research|December 1, 1982
Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNAD J Herrick, P P Major, D W Kufe
Pageof 4